Literature DB >> 22472312

A case of acute suicidality following excessive caffeine intake.

Aleksandra Szpak1, Danny Allen.   

Abstract

Energy and stimulant drinks which contain caffeine provide enlivening effects, reduce fatigue and improve concentration and endurance. However, consumers may also experience physical and psychological side effects as a result of excessive consumption of caffeine within these drinks. Caffeine is known to exacerbate or induce some psychiatric conditions such as anxiety, panic attacks, psychosis and mania. Here we discuss a case of acute suicidality following sleep deprivation after the excessive consumption of a popular energy drink. We are concerned that such widely available stimulant drinks should contain health warnings or advice regarding moderating consumption.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472312     DOI: 10.1177/0269881112442788

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  5 in total

1.  Manic Episode Following Ingestion of Caffeine Pills: A Case Report.

Authors:  Boris M Kiselev; Shady S Shebak; Thomas R Milam
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

2.  A case of suicide by ingestion of caffeine.

Authors:  Alessandro Bonsignore; Sara Sblano; Fulvia Pozzi; Francesco Ventura; Alessandro Dell'Erba; Cristian Palmiere
Journal:  Forensic Sci Med Pathol       Date:  2014-04-27       Impact factor: 2.007

3.  Psychiatric and medical management of marijuana intoxication in the emergency department.

Authors:  Quan M Bui; Scott Simpson; Kimberly Nordstrom
Journal:  West J Emerg Med       Date:  2015-04-09

Review 4.  A Review of Energy Drinks and Mental Health, with a Focus on Stress, Anxiety, and Depression.

Authors:  Gareth Richards; Andrew P Smith
Journal:  J Caffeine Res       Date:  2016-06-01

5.  Psychopathology Related to Energy Drinks: A Psychosis Case Report.

Authors:  Daniel Hernandez-Huerta; Maria Martin-Larregola; Jorge Gomez-Arnau; Javier Correas-Lauffer; Helen Dolengevich-Segal
Journal:  Case Rep Psychiatry       Date:  2017-01-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.